Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ITPR-interacting domain-containing protein 1 (ITPRID1) is a human protein encoded by the ITPRID1 gene, also known as CCDC129. It is characterized by the presence of coiled-coil domains. ITPRID1 is predicted to enable signaling receptor binding activity, but its precise molecular function remains largely uncharacterized. Some studies suggest a potential role in apoptosis and neuronal death pathways, possibly acting as a mediator between the tumor suppressor p53 and BAX proteins, but direct evidence for these functions is limited[1][7][8]. Disease associations identified include lung acinar adenocarcinoma and Tn polyagglutination syndrome[2]. There are no known drugs that directly target this protein, and its utility as a biomarker or therapeutic target is currently unsupported by available evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ITPR-interacting domain-containing protein 1 (ITPRID1).